Kailera Therapeutics Inc (KLRA)

Kailera Therapeutics Inc experienced significant insider activity on April 20, 2026. Multiple entities and individuals, including Bain Capital and Andrew T. Kaplan, executed substantial share purchases. These transactions represent the most recent recorded movements, occurring over three months ago. No further trading data has been reported since that date.
Ticker: KLRA Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 20 Apr 2026
Value US$4,094,627.63 | Price 155.47 | Shares 84,618 (-13.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-04-22 2026-04-20 B Purchase Large shareholder
84,618 -13.2%
155.47
US$4,094,628
84,618 -13.2% 155.47 US$4,094,628
2026-04-20 2026-04-20 B Purchase Large shareholder
36,356 -48.7%
430.90
US$4,300,214
36,356 -48.7% 430.90 US$4,300,214
2026-04-20 2026-04-20 B Purchase Non-Executive Director Large shareholder
19,285 -16.8%
235.50
US$3,727,967
19,285 -16.8% 235.50 US$3,727,967
2026-04-20 2026-04-20 B Purchase Large shareholder
1,562,500 +7.4%
16.00
US$25,000,000
1,562,500 +7.4% 16.00 US$25,000,000
2026-04-20 2026-04-20 B Purchase Non-Executive Director Large shareholder
8,398,438 +47.0%
16.00
US$134,375,008
8,398,438 +47.0% 16.00 US$134,375,008